0.34
+0.0051(+1.51%)
Currency In USD
| Previous Close | 0.34 |
| Open | 0.34 |
| Day High | 0.36 |
| Day Low | 0.33 |
| 52-Week High | 3.65 |
| 52-Week Low | 0.3 |
| Volume | 676,584 |
| Average Volume | 704,650 |
| Market Cap | 22.99M |
| PE | -0.32 |
| EPS | -1.08 |
| Moving Average 50 Days | 0.39 |
| Moving Average 200 Days | 1.06 |
| Change | 0.01 |
If you invested $1000 in Generation Bio Co. (GBIO) since IPO date, it would be worth $13.89 as of July 06, 2025 at a share price of $0.343. Whereas If you bought $1000 worth of Generation Bio Co. (GBIO) shares 3 years ago, it would be worth $49.49 as of July 06, 2025 at a share price of $0.343.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Generation Bio to Present at the 2025 Jefferies Global Healthcare Conference
GlobeNewswire Inc.
May 28, 2025 10:59 AM GMT
CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune diseases, announced that Geoff McDonough, M.D., president
Generation Bio Reports Recent Business Highlights and First Quarter 2025 Financial Results
GlobeNewswire Inc.
May 07, 2025 8:05 PM GMT
- Company continues to advance its strategy to develop first-in-class treatments for T cell-driven autoimmune diseases using its cell-targeted lipid nanoparticle (ctLNP) technology to deliver siRNA - Lead target and portfolio strategy to be announc
Generation Bio to Present at the Needham 24th Annual Virtual Healthcare Conference
GlobeNewswire Inc.
Apr 02, 2025 10:59 AM GMT
CAMBRIDGE, Mass., April 02, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune diseases, announced that Geoff McDonough, M.D., preside